Getinge Beats Q3 Profit Views
Swedish medical equipment maker Getinge reported third quarter core earnings above expectations driven by pricing and product mix. Adjusted EBITA rose eighteen percent to 1.28 billion crowns. The company also confirmed its full year organic sales growth forecast.
Xurve View
Insights:
Xurve View
Getinge reported third-quarter adjusted EBITA rose 18% to 1.28 billion Swedish crowns ($129 million), beating market estimates on pricing discipline. The Sweden-based medical equipment maker topped the 1.19 billion crown average analyst forecast compiled by the company. CEO Mattias Perjos navigated ongoing supply chain headwinds and import levies from the United States.
